No, not an April Fools’ joke – BioBridge Ltd, the Cambridge-based independent life science innovation consultancy, was founded in 1989 and has been at the forefront of biotechnology and life science advances since then, from a ground-breaking report for Frost&Sullivan on biotechnology in animal breeding and production, via helping establish new approaches to xenogeneic therapies and biopharming, to current involvement in the latest green and blue biotechnology advances.
Dr Meredith Lloyd-Evans, founder and CEO of BioBridge Ltd, said “Since we started, we have  worked with  over 100 clients from  individuals to giant corporations through start-ups and SMEs to governments, spread over the world from Japan via Europe to Canada and the East coast of America. We are very grateful to our clients for their support, especially our long-term relationships stretching from 10 to 25 years. Using our expertise in innovation and exploitation in Life Sciences, we’ve been able to work with and help creative people and companies build strong advances in marine and crop biotechnology, tissue engineering, animal health, medical devices and industrial biotechnology. Our expertise allows us to carry out highly- focused projects for companies on specific topics, and  the  breadth  of  experience  means  we can offer support to strategic decisions at top level, as well.”
Looking to the future, Meredith is strongly involved in efforts to build sustainable economies based on marine and aquaculture biomass, in areas such as blue bioproducts for chemical, plastics and health uses, and is helping create European and international groupings to achieve this, via the BioMarine organisation. In Animal Health, he is working with the US-based Vaxiam Group to accelerate productive linkages between European and Chinese companies and research activities. In dermatological healthcare, BioBridge has successfully helped companies find new ingredients, especially from natural sources, and new products for management of long-term skin conditions. He is an active member of IBioIC, the Scotland-based Industrial Biotechnology Innovation centre, and works with IBioIC and the Bio-Based Industries Consortium on marine biotechnology workshops and seminars. In Spring and Summer 2019, he will be contributing to round-tables, panel discussions and EU-supported conferences in the Blue Economy. Work, and the opportunity to contribute to progress, does not stop!